Oncotype DX Breast Cancer Testing
East Sussex Healthcare NHS Trust
This tender has closed
The submission deadline for this contract has passed. There may be more active services tenders from East Sussex Healthcare NHS Trust, and hundreds more across the UK public sector.
Key details
Procurement
- 85111800 Pathology services
What happened
East Sussex Healthcare NHS Trust awarded this contract to Exact Sciences UK, Ltd. worth £272,700 on 2 Mar 2026. The contract runs until 31 Mar 2027.
Description
Oncotype DX is a validated genomic assay recommended by NICE (DG34) for guiding chemotherapy decisions in specific cohorts of early breast cancer. It provides a Recurrence Score that stratifies patients into groups where chemotherapy is beneficial versus where endocrine therapy alone is sufficient.
Additional information: This is a call off contract from framework 2023/S 000-028831 based on previous contracts usage.
Awarded supplier
Contact
Identifiers
Explore related tenders
External ID: cf-ocds-b5fd17-6952487a-f7d5-42df-ae7a-052feb2a20e7 • Added 29 April 2026